// COMPANY
Bambusa Therapeutics
SECTOR BIOTECHMENTIONS 2LAST SEEN OCTOBER 13, 2026
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·OCTOBER 13, 2026
“Bambusa Therapeutics, an RA Capital-backed developer of drugs for eczema and inflammation, filed for a US IPO.”
02
funding·Axios Pro Rata·OCTOBER 13, 2026
“Aspen Neuroscience and Bambusa Therapeutics filed for IPOs.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.